Investing News Patent dispute over Gilead’s HIV and HBV medications resolved with many generic drugmakers September 12, 2022
Investing News Gilead Trodelvy Has Shown Promise in Breast Cancer Patients’ Clinical Trials, Regardless of HER2 Mutation September 5, 2022
Investing News 3 Healthcare Equities That May Benefit From Senate Democrats’ $21 Billion Proposal in New COVID-19 Funding August 4, 2022
Investing News GILEAD SCIENCES, Inc. IMPROVES ITS OUTLOOK FOR 2022 AS ITS HIV AND CANCER CHARTER THRIVE August 3, 2022